The expression of CD86 in CD3+CD56+ NKT cells is associated with the occurrence and prognosis of sepsis-associated encephalopathy in sepsis patients: a prospective observational cohort study

Bolton CF, Young GB. Managing the nervous system effects of sepsis. Chest. 2007;131(5):1273–4. Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8(10):557–66. Ren C, Yao RQ, Zhang H, Feng YW, Yao YM. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020;17(1):14. Zhang LN, Wang XT, Ai YH, Guo QL, Huang L, Liu ZY, Yao B. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008–2011. Chin Med J (Engl). 2012;125(5):828–31. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94. Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43(8):1075–84. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. Maddux AB, Hiller TD, Overdier KH, Pyle LL, Douglas IS. Innate immune function and organ failure recovery in adults with sepsis. J Intensive Care Med. 2019;34(6):486–94. Peidaee E, Sheybani F, Naderi H, Khosravi N, Jabbari Nooghabi M. The etiological spectrum of febrile encephalopathy in adult patients: a cross-sectional study from a developing country. Emerg Med Int. 2018;2018:3587014. Zaghloul N, Addorisio ME, Silverman HA, Patel HL, Valdes-Ferrer SI, Ayasolla KR, Lehner KR, Olofsson PS, Nasim M, Metz CN, et al. Forebrain cholinergic dysfunction and systemic and brain inflammation in murine sepsis survivors. Front Immunol. 2017;8:1673. Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol. 2009;129(7):1628–42. Jiang W, Li X, Wen M, Liu X, Wang K, Wang Q, Li Y, Zhou M, Liu M, Hu B, et al. Increased percentage of PD-L1(+) natural killer cells predicts poor prognosis in sepsis patients: a prospective observational cohort study. Crit Care. 2020;24(1):617. Jiang W, Li X, Ding H, Wang K, Liu X, Wang Q, Li Y, Zhou M, Chen S, Zhong W, et al. PD-1 in Tregs predicts the survival in sepsis patients using sepsis-3 criteria: a prospective, two-stage study. Int Immunopharmacol. 2020;89(Pt A):107175. Peng Y, Luo G, Zhou J, Wang X, Hu J, Cui Y, Li XC, Tan J, Yang S, Zhan R, et al. CD86 is an activation receptor for NK cell cytotoxicity against tumor cells. PLoS ONE. 2013;8(12):e83913. Newton S, Ding Y, Chung CS, Chen Y, Lomas-Neira JL, Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt). 2004;5(4):375–83. van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kolgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol. 2004;112(1):8–23. Mercer JC, Ragin MJ, August A. Natural killer T cells: rapid responders controlling immunity and disease. Int J Biochem Cell Biol. 2005;37(7):1337–43. Nolan A, Kobayashi H, Naveed B, Kelly A, Hoshino Y, Hoshino S, Karulf MR, Rom WN, Weiden MD, Gold JA. Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. Plos One. 2009;4(8):e6600. Lin B, Jia X, Xie Z, Su T, Wei Y, Tang J, Yang C, Cui C, Liu J. Vascular endothelial cells activate peripheral natural killer T cells and participate in regulation of downstream immune cascades in patients with sepsis. Med Sci Monit. 2018;24:7387–98. Fan LL, Wang YJ, Nan CJ, Chen YH, Su HX. Neutrophil-lymphocyte ratio is associated with all-cause mortality among critically ill patients with acute kidney injury. Clin Chim Acta. 2019;490:207–13. Lorente L, Martin MM, Ortiz-Lopez R, Alvarez-Castillo A, Ruiz C, Uribe L, et al. Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(5):235–40. Hao Y, Qi Z, Ding Y, Yu X, Pang L, Zhao T. Effect of interventional therapy on IL-1beta, IL-6, and neutrophil-lymphocyte ratio (NLR) levels and outcomes in patients with ischemic cerebrovascular disease. Med Sci Monit. 2019;25:610–7. Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372–6. Cato LD, Wearn CM, Bishop JRB, Stone MJ, Harrison P, Moiemen N. Platelet count: a predictor of sepsis and mortality in severe burns. Burns. 2018;44(2):288–97. Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: interaction effect with disease severity-a retrospective study. BMJ Open. 2019;9(1):e022896. Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T, Zeba S, Milosavljevic S, Stankovic N, Abazovic D, et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediat Inflamm. 2018;2018:3758068. Lu CX, Qiu T, Tong HS, Liu ZF, Su L, Cheng B. Peripheral T-lymphocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis. Exp Ther Med. 2016;11(3):1077–84. Pecker M, Adams M, Graham W. The systemic capillary leak syndrome. Ann Intern Med. 2011;155(5):335 (author reply 335-336). Chen J, Shi X, Diao M, Jin G, Zhu Y, Hu W, Xi S. A retrospective study of sepsis-associated encephalopathy: epidemiology, clinical features and adverse outcomes. BMC Emerg Med. 2020;20(1):77. Grmec S, Gasparovic V. Comparison of APACHE II, MEES and Glasgow Coma Scale in patients with nontraumatic coma for prediction of mortality. Acute Physiology and Chronic Health Evaluation Mainz Emergency Evaluation System. Crit Care. 2001;5(1):19–23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29. Martin-Loeches I, Guia MC, Vallecoccia MS, Suarez D, Ibarz M, Irazabal M, Ferrer R, Artigas A. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care. 2019;9(1):26. Su YY, Li X, Li SJ, Luo R, Ding JP, Wang L, Cao GH, Wang DY, Gao JX. Predicting hospital mortality using APACHE II scores in neurocritically ill patients: a prospective study. J Neurol. 2009;256(9):1427–33.